N-acetyl-L-cysteine potentiates interleukin-1β induction of nitric oxide synthase: Role of p44/42 mitogen-activated protein kinases

Hypertension

Volumn 35, Issue 4, 2000, Pages 914-918

  Jiang, Bingbing ^a   Brecher, Peter ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcysteine; Interleukins; Muscle; Nitric oxide synthase; Protein kinases; Smooth; Vascular

Indexed keywords

ACETYLCYSTEINE; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0034028644     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.4.914     Document Type: Article

References (24)

1. Moncada S, Higgs EA. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest. 1991;21:361-374.
2. Luoma JS, Strålin P, Marklund SL, Hiltunen TP, Särkioja T, Yä-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1998;18:157-167.
3. Buttery LD, Sprmgall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
4. Yan Z, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res. 1996;79:38-44.
5. Yan Z, Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res. 1998;82:21-29.
6. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 1994;28:34-39.
7. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83: 1774-1777.
8. Shears LL II, Kibbe MR, Murdock AD, Billiar TR, Lizonova A, Kovesdi I, Watkins SC, Tzeng E. Efficient inhibition of intimai hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg. 1998;187:295-306.
9. Takizawa T, Gu M, Chobanian AV, Brecher P. Effect of nitric oxide on DNA replication induced by angiotensin II in rat cardiac fibroblasts. Hypertension. 1997;30:1035-1040.
10. Tzeng E, Kim YM, Pitt BR, Lizonova A, Kovesdi I, Billiar TR. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery. 1997;122:255-263.
11. Jiang B, Haverty M, Brecher P. N-Acetyl-L-cysteine enhances interleukin-1β-induced nitric oxide synthase expression. Hypertension 1999;34:574-579.
12. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription. J Biol Chem. 1998;273:6607-6610.
13. Ajizian SJ, English BK, Meals EA. Specific inhibitors of p38 and extra-cellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ. J Infect Dis. 1999;179:939-944.
14. Guan Z, Baier LD, Morrison AR. p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E, biosynthesis stimulated by interleukin-1β. J Biol Chem. 1997;272:8083-8089.
15. Silva JD, Pierrat B, Mary JL, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem. 1997;272: 28373-28380.
16. Faure V, Hecquet C, Courtois Y, Goureau O. Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells. J Biol Chem. 1999;274:4794-4800.
17. Larsen CM, Wadt KAW, Juhl LF, Andersen HU, Karlsen AE, Su MSS, Seedorf K, Shapiro L, Dinarello CA, Mandrup-Poulsen T. Interleukin-1β-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem. 1998;273:15294-15300.
18. Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. J Biol Chem. 1996;271:1111-1117.
19. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
20. Cotgreave IA. N-Acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol. 1997;38: 205-227.
21. Aruoma OJ, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical. superoxide and hypochlorous acid. Free Radic Biol Med. 1989;6: 593-597.
22. Chen CC, Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol. 1999;55:481-488.
23. Badger AM, Cook MN, Lark MW, Newman-Tarr TM, Swift BA, Nelson AH. Barone FC, Kumar S. SB203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production, and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes. J Immunol. 1998;161: 467-473.
24. Yan CYI, Greene LA. Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway. J Neurosci. 1998;18:4042-4049.